1. MARKETS
  2. SECTOR : PHARMA & BIOTECH
  3. INDUSTRY : MAJOR PHARMACEUTICALS
  4. EXELIXIS INC
Exelixis Inc XNAS: EXEL

Exelixis Inc Live Stock Price Today, Share Analysis and Chart

Turnaround Potential
about

Exelixis Inc is a biopharmaceutical firm that discovers, develops, and commercializes treatments for cancer. Its molecule, cabozantinib, is indicated for the treatment of patients with metastatic medullary thyroid cancer under the name Cometriq and f...

Read More
44.75 -0.39 (-0.86%)
38.20% Gain from 52W Low
2.3M
XNAS Volume

XNAS 25 Feb, 2026 4:30 PM (EST)

Watchlist

Portfolio

Alert
Durability score
Medium Financial Strength
50.0 / 100
Valuation Score
Mid Valuation
49.5 / 100
Momentum Score
Technically Moderately Bullish
64.0 / 100
Turnaround Potential These stocks have average financials and valuation, but strong momentum indicating buying interest View Similar Embed DVM
Analyst Price Target
47
1Yr Price target upside is 5%
18 analysts

18

S

4

W

5

O

1

T

SWOT Analysis

Exelixis Inc Live Price Chart

Switch to TradingView


Loading Fundamental data..


Loading data..